$ATEX

Heard William sold $4.2M of ATEX (indirect holdings)

Heard William sold 46,400 indirectly-held shares of Anterix Inc. (ATEX) at $90.11 ($4.18M total) on 2026-08-14.

Original reporting
SEC EDGAR · Heard William
Published Aug 18, 2026, 9:38 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 18, 2026, 9:56 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ATEX
Neutral
medium confidence
Mentioned
$ATEX
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ATEXNeutralLow
01

Why it matters

The only new fact is the disclosed sale size, price, and post-transaction holdings; the article does not include any new operational, financial, legal, or regulatory developments for ATEX.

02

Market read

Traders may briefly reassess sentiment around ATEX due to the disclosed insider selling, but there is no fundamental catalyst in the text.

03

What to watch

The transaction is indirect and the text does not confirm whether it is part of a broader pattern or driven by personal circumstances; absence of a stated 10b5-1 plan may increase speculation but is not proof of bearish fundamentals.

Relevance 6/10Novelty 3/10Timing: filed 2026-08-18, sale dated 2026-08-14

Background

This is a SEC Form 4 insider transaction disclosure for Anterix Inc. (ATEX) by director William Heard, reported via EDGAR.

Company-level read

Ticker impact

$ATEXNeutralMedium confidence
Context

Anterix director William Heard filed a Form 4 selling 46,400 shares on 2026-08-14 for about $4.18M, indirect holdings.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven and typically fades unless accompanied by other disclosures.

Evidence & confidence

Form 4 insider sales are common and the article provides no 10b5-1 plan, but also no accompanying operational or financial catalyst for ATEX.

Market effects

No sector-level signal is provided beyond a single insider transaction.

None indicated.

None indicated.

Counterpoint

The sale could be routine liquidity management or tax-related, especially since the filing does not describe any negative company-specific development.

Key entities

  • Anterix Inc.

    Subject of the Form 4 insider transaction disclosure.

  • William Heard

    Director who sold shares via an open-market sale, indirect holdings.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ATEXMed

Anterix (ATEX) Q1 2027 Earnings Call Transcript

Anterix (ATEX) reported Q1 2027 revenue of $2M, up from $1.4M YoY, with net income of $240K. Operating expenses decreased to $12.9M. The company has $116M in cash, no debt, and $226.7M left for share repurchases. Management highlighted 12 active deals, spectrum clearing progress, and support for SpaceX's FCC proposal. CFO warned of potential higher costs if spectrum clearing is accelerated.

$ATEXMed

Anterix Inc. (ATEX): Results of Operations and Financial Condition

Anterix Inc. (ATEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 atex-06302026xpressrelease.htm EX-99.1 Document Anterix Inc. Reports First Quarter Fiscal Year 2027 Results Woodland Park, NJ – August 11, 2026 – Anterix (NASDAQ: ATEX) today announced its first quarter fiscal 2027 results and filed its Form 10-Q for the three months en

$ATEXMed

Anterix Inc. (ATEX): Results of Operations and Financial Condition

Anterix Inc. (ATEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 atex-20260331xpressrelease.htm EX-99.1 Document Anterix Inc. Reports Full Fiscal Year 2026 Results Woodland Park, NJ – June 10, 2026 – Anterix (NASDAQ: ATEX) today announced fiscal 2026 fourth quarter and full fiscal year financial results for the year ended March 31, 2